SYNFIRE
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 07 Mar 2024)
What this means for you
Registered since 19 Sept 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87186497
- Registration number
- 5292724
- Mark type
- Stylized text
- Filed
- 28 Sept 2016
- Published for opposition
- 28 Feb 2017
- Registered
- 19 Sept 2017
- Attorney of record
- Kathryn Starshak
Goods and services
- Class 001 — Chemicals: Cells for medical and clinical research for the development of pharmaceutical products
Owner
- Neucyte, Inc., Mountain View, CA, US
- Neucyte, Inc., Palo Alto, CA, US
- Neucyte, Inc., Palo Alto, CA, US
Prosecution history
- 07 Mar 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 07 Mar 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 07 Mar 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Sept 2023 — TEAS SECTION 8 & 15 RECEIVED
- 19 Sept 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 19 Sept 2017 — REGISTERED-PRINCIPAL REGISTER
- 17 Aug 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 Aug 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Jul 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Jul 2017 — USE AMENDMENT FILED
- 26 Jul 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Jul 2017 — TEAS STATEMENT OF USE RECEIVED
- 25 Apr 2017 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Feb 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Feb 2017 — PUBLISHED FOR OPPOSITION